Incidence immunoassay for distinguishing recent from established HIV-1 infection in therapy-naive populations

Abstract

An assay for anti-p24 IgG3 reactivity would provide an estimate of the incidence of HIV infection that may be applicable for epidemiological surveys as well as for monitoring new infections during vaccine trials and for managing treatment programmes.